These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 35835862

  • 1. Relapse rates after withdrawal of thiopurines in patients with inflammatory bowel disease.
    Ranjan MK, Vuyyuru SK, Kante B, Kumar P, Mundhra SK, Golla R, Sharma R, Sahni P, Das P, Makharia G, Kedia S, Ahuja V.
    Int J Colorectal Dis; 2022 Aug; 37(8):1817-1826. PubMed ID: 35835862
    [Abstract] [Full Text] [Related]

  • 2. Poor Drug Sustainability in Inflammatory Bowel Disease Patients in Clinical Remission on Thiopurine Monotherapy.
    Balram B, Lubov J, Theoret Y, Afif W, Bitton A, Wild G, Lakatos PL, Bessissow T.
    Dig Dis Sci; 2021 May; 66(5):1650-1657. PubMed ID: 32591969
    [Abstract] [Full Text] [Related]

  • 3. Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients.
    Kennedy NA, Kalla R, Warner B, Gambles CJ, Musy R, Reynolds S, Dattani R, Nayee H, Felwick R, Harris R, Marriott S, Senanayake SM, Lamb CA, Al-Hilou H, Gaya DR, Irving PM, Mansfield J, Parkes M, Ahmad T, Cummings JR, Arnott ID, Satsangi J, Lobo AJ, Smith M, Lindsay JO, Lees CW.
    Aliment Pharmacol Ther; 2014 Dec; 40(11-12):1313-23. PubMed ID: 25284134
    [Abstract] [Full Text] [Related]

  • 4. Thiopurine monotherapy is effective in ulcerative colitis but significantly less so in Crohn's disease: long-term outcomes for 11 928 patients in the UK inflammatory bowel disease bioresource.
    Stournaras E, Qian W, Pappas A, Hong YY, Shawky R, UK IBD BioResource Investigators, Raine T, Parkes M, UK IBD Bioresource Investigators.
    Gut; 2021 Apr; 70(4):677-686. PubMed ID: 33004550
    [Abstract] [Full Text] [Related]

  • 5. Minimal risk of lymphoma and non-melanoma skin cancer despite long-term use of thiopurines in patients with inflammatory bowel disease: A longitudinal cohort analysis from northern India.
    Ranjan MK, Kante B, Vuyyuru SK, Kumar P, Mundhra SK, Golla R, Sharma R, Sahni P, Das P, Makharia G, Kedia S, Ahuja V.
    J Gastroenterol Hepatol; 2022 Aug; 37(8):1544-1553. PubMed ID: 35501287
    [Abstract] [Full Text] [Related]

  • 6. Do Thiopurines Reduce the Risk of Surgery in Elderly Onset Inflammatory Bowel Disease? A 20-Year National Population-Based Cohort Study.
    Alexakis C, Saxena S, Chhaya V, Cecil E, Curcin V, Pollok R.
    Inflamm Bowel Dis; 2017 Apr; 23(4):672-680. PubMed ID: 28151735
    [Abstract] [Full Text] [Related]

  • 7. Thiopurines Have Sustained Long-term Effectiveness in Patients with Inflammatory Bowel Disease, Which is Independent of Disease Duration at Initiation: A Propensity Score Matched Analysis.
    Ranjan MK, Kumar P, Vuyyuru SK, Kante B, Mundhra SK, Golla R, Virmani S, Sharma R, Sahni P, Das P, Kalaivani M, Upadhyay AD, Makharia G, Kedia S, Ahuja V.
    J Crohns Colitis; 2024 Feb 26; 18(2):192-203. PubMed ID: 37584328
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Complete Endoscopic Healing Is Associated With Lower Relapse Risk After Anti-TNF Withdrawal in Inflammatory Bowel Disease.
    Mahmoud R, Savelkoul EHJ, Mares W, Goetgebuer R, Witteman BJM, de Koning DB, van Tuyl SAC, Minderhoud I, Lutgens MWMD, Akol-Simsek D, van Schaik FDM, Fidder HH, Jansen JM, van Boeckel PGA, Mahmmod N, Horjus-Talabur Horje CS, Römkens TEH, Colombel JF, Hoentjen F, Jharap B, Oldenburg B, Dutch Initiative on Crohn’s and Colitis (ICC) and the AWARE study group.
    Clin Gastroenterol Hepatol; 2023 Mar 26; 21(3):750-760.e4. PubMed ID: 36055567
    [Abstract] [Full Text] [Related]

  • 10. Azathioprine monotherapy withdrawal in inflammatory bowel diseases: A retrospective mono-centric study.
    Crepaldi M, Maniero D, Massano A, Pavanato M, Barberio B, Savarino EV, Zingone F.
    World J Gastroenterol; 2023 Jul 21; 29(27):4334-4343. PubMed ID: 37545640
    [Abstract] [Full Text] [Related]

  • 11. Withdrawal of Azathioprine in Inflammatory Bowel Disease Patients Who Sustain Remission: New Risk Factors for Relapse.
    Iborra M, Herreras J, Boscá-Watts MM, Cortés X, Trejo G, Cerrillo E, Hervás D, Mínguez M, Beltrán B, Nos P.
    Dig Dis Sci; 2019 Jun 21; 64(6):1612-1621. PubMed ID: 30604371
    [Abstract] [Full Text] [Related]

  • 12. Systematic Review of Effects of Withdrawal of Immunomodulators or Biologic Agents From Patients With Inflammatory Bowel Disease.
    Torres J, Boyapati RK, Kennedy NA, Louis E, Colombel JF, Satsangi J.
    Gastroenterology; 2015 Dec 21; 149(7):1716-30. PubMed ID: 26381892
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Long-term Safety and Efficacy of Low-dose Azathioprine and Allopurinol Cotherapy in Inflammatory Bowel Disease: A Large Observational Study.
    Pavlidis P, Stamoulos P, Abdulrehman A, Kerr P, Bull C, Duley J, Ansari A.
    Inflamm Bowel Dis; 2016 Jul 21; 22(7):1639-46. PubMed ID: 27271488
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Risk of lymphoma in patients with ulcerative colitis treated with thiopurines: a nationwide retrospective cohort study.
    Khan N, Abbas AM, Lichtenstein GR, Loftus EV, Bazzano LA.
    Gastroenterology; 2013 Nov 21; 145(5):1007-1015.e3. PubMed ID: 23891975
    [Abstract] [Full Text] [Related]

  • 17. Long-term clinical outcome after thiopurine discontinuation in elderly IBD patients.
    Jorissen C, Verstockt B, Schils N, Sabino J, Ferrante M, Vermeire S.
    Scand J Gastroenterol; 2021 Nov 21; 56(11):1323-1327. PubMed ID: 34399630
    [Abstract] [Full Text] [Related]

  • 18. A trial of mercaptopurine is a safe strategy in patients with inflammatory bowel disease intolerant to azathioprine: an observational study, systematic review and meta-analysis.
    Kennedy NA, Rhatigan E, Arnott ID, Noble CL, Shand AG, Satsangi J, Lees CW.
    Aliment Pharmacol Ther; 2013 Nov 21; 38(10):1255-66. PubMed ID: 24117596
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review.
    Fraser AG, Orchard TR, Jewell DP.
    Gut; 2002 Apr 21; 50(4):485-9. PubMed ID: 11889067
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.